title: [Effectiveness of and tolerance to pravastatin in the short-term treatment of primary hypercholesterolemia].
abstract: In this study, 9 patients with primary hypercholesterolemia were treated with pravastatin. They received a daily dose of 20 mg for 12 weeks. Results showed a significant reduction in total and LDL cholesterol, whereas no significant difference was observed in HDL and triglyceride levels after treatment. No adverse effects were observed.
authors.affiliation: Cattedra di Clinica Medica, Università degli Studi di Pavia.
authors.forename: P
authors.initials: P
authors.lastname: Marnini
authors.forename: P
authors.initials: P
authors.lastname: Bonfanti
authors.forename: E
authors.initials: E
authors.lastname: Piantanida
authors.forename: A
authors.initials: A
authors.lastname: Venco
mesh_terms: D000368:Aged; D002784:Cholesterol / Q000097:blood; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D017035:Pravastatin / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D002784:Cholesterol; D017035:Pravastatin
vernacular_title: Efficacia e tollerabilità della pravastatina nel trattamento a breve termine delle ipercolesterolemie primarie.